Tarry W C, Makhoul R G, Tisnado J, Posner M P, Sobel M, Lee H M
Department of Surgery, Medical College of Virginia, Richmond 23298-0108.
Ann Vasc Surg. 1994 Nov;8(6):583-90. doi: 10.1007/BF02017416.
Massive deep venous thrombosis with marked venous outflow obstruction can result in limb loss or end-organ injury. Systemically administered drugs may not reach thrombi in therapeutic concentrations and surgical and thrombolytic strategies carry a small but real risk of pulmonary embolus--similar to the risks with anticoagulation alone. We therefore developed a strategy in which catheter-directed thrombolysis was used to deliver high concentrations of a plasminogen activator directly to the thrombus combined with placement of a downstream Greenfield filter to protect patients from pulmonary embolus. From 1984 to 1993 six patients were treated with this regimen. All had severe symptoms of less than 4 days' duration. On radiologic evaluation four patients had large iliofemoral and/or inferior vena cava thrombosis, one had subclavian/innominate vein thrombosis, and one had transplant renal vein/iliofemoral/inferior vena cava thrombosis. A Greenfield filter was first placed downstream prior to imbedding an infusion catheter in the greatest mass of thrombus for subsequent infusion of urokinase (n = 4) or streptokinase (n = 2). In four patients the catheter traversed the Greenfield filter. All patients were given bolus lytic therapy followed by maintenance infusions ranging in duration from 24 hours to 12 days. Five patients remained on heparin simultaneously. Clot lysis was achieved in all patients with hemodynamic, symptomatic, and arteriographic improvement. There were no deaths, pulmonary emboli, or complications of filter placement. One patient had minor bleeding at the puncture site and another had catheter-related infection.(ABSTRACT TRUNCATED AT 250 WORDS)
严重的深静脉血栓形成并伴有明显的静脉流出道梗阻可导致肢体丧失或终末器官损伤。全身给药的药物可能无法达到治疗浓度的血栓部位,而手术和溶栓策略虽导致肺栓塞的风险较小但真实存在——这与单纯抗凝治疗的风险相似。因此,我们制定了一种策略,即采用导管定向溶栓将高浓度的纤溶酶原激活剂直接输送至血栓部位,并同时放置下游格林菲尔德滤器以保护患者免受肺栓塞。1984年至1993年期间,6例患者接受了该治疗方案。所有患者的严重症状持续时间均不到4天。经影像学评估,4例患者存在大的髂股静脉和/或下腔静脉血栓形成,1例有锁骨下/无名静脉血栓形成,1例有移植肾静脉/髂股静脉/下腔静脉血栓形成。首先在血栓最大部位植入输液导管之前,在其下游放置格林菲尔德滤器,随后输注尿激酶(n = 4)或链激酶(n = 2)。4例患者的导管穿过了格林菲尔德滤器。所有患者均接受了大剂量溶栓治疗,随后进行持续24小时至12天不等的维持输注。5例患者同时接受肝素治疗。所有患者均实现了血栓溶解,血流动力学、症状和血管造影均有改善。无死亡、肺栓塞或滤器放置相关并发症发生。1例患者穿刺部位有轻微出血,另1例有导管相关感染。(摘要截选至250字)